July 25, 2016 | FAH Policy Blog Team
Category: Health Care Delivery, Pharmaceuticals
The CEO of a hospital in rural Iowa expressed his support for common sense solutions to help solve the prescription drug pricing crisis in an op-ed published in Sunday’s Des Moines Register.
Phil Noel, CEO of Ottumwa Regional Health Center in Ottumwa Iowa, laid out how rising medication costs are effecting his hospital and the patients it serves.
“This problem is acute. The high cost of cancer drugs made it impossible for our organization to continue to offer medical oncology. Additionally, the boutique infusion drugs have increased in usage and cost with a high financial burden to patients and hospitals that administer them,” he wrote.
Ottumwa Regional Health Centers is owned by Federation of American Hospitals member company RCCH HealthCare Partners.
July 20, 2016 | FAH Policy Blog Team
Category: FAH News, Legislation, Pharmaceuticals
The Federation of American Hospitals commented to the Food and Drug Administration Monday on the agency’s latest detailed draft guidance document implementing provisions of the revised Section 503A of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FAH letter expresses serious concerns about the current draft guidance and its impact on the provision of appropriate patient care.
July 14, 2016 | FAH Policy Blog Team
Category: Affordable Care Act, FAH News, Legislation
A survey of a bipartisan group of more than 40 health care experts about the Affordable Care Act (ACA) recently done by POLITICO came to a simple conclusion – the law is here to stay, but it does need to be fixed.
July 13, 2016 | FAH Policy Blog Team
Today, Health Affairs published a new blog authored by Federation of American Hospitals President and CEO Chip Kahn entitled Dynamic Debate: Health Affairs Forum Begins Value-Based Payment Discussion. It looks at the current state of health care payment systems and examines ways they can be improved.